Alvogen, Inc recalls Clindamycin Injection USP; 300 mg/2 mL (150 mg/mL). 2 mL Single-dose ADD-VANTAGE Vial, Rx Only, Manufactured for Alvogen
Recalled July 12, 2017 · FDA recall D-0939-2017 · Alvogen
Hazard
Lack of Assurance of Sterility · FDA Class II
Units
5,100 2 mL vials
Sold at
Nationwide
Description
Lack of Assurance of Sterility
Product
Clindamycin Injection USP; 300 mg/2 mL (150 mg/mL). 2 mL Single-dose ADD-VANTAGE Vial, Rx Only, Manufactured for Alvogen, Inc., Pine Brook, NJ 07058, NDC 47781-462-69
Manufacturer(s)
Alvogen, Inc
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →